Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Bone Sarcoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Bone Sarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Bone Sarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Bone Sarcoma pipeline landscape. The report provides compr...
April 2021
35 pages
Brain Cancer (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Brain Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Brain Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Brain Cancer pipeline landscape. The report provides compr...
April 2021
90 pages
Brain Tumor (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Brain Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Brain Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Brain Tumor pipeline landscape. The report provides comprehe...
April 2021
75 pages
Brenner Tumor (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Brenner Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Brenner Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Brenner Tumor pipeline landscape. The report provides co...
April 2021
30 pages
Burkitt Lymphoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Burkitt Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Burkitt Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Burkitt Lymphoma pipeline landscape. The report pr...
April 2021
110 pages
Cachexia (Musculoskeletal) - Drugs in Development, 2021
US$ 2,000.00
Cachexia (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Cachexia (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Cachexia pipeline landscape. The report provides com...
April 2021
50 pages
Calcium Sensing Receptor - Drugs in Development, 2021
US$ 3,000.00
Calcium Sensing Receptor - Drugs in Development, 2021 SUMMARY Calcium Sensing Receptor - Drugs in Development, 2021 provides in depth analysis on Calcium Sensing Receptor targeted pipeline therapeutic...
April 2021
35 pages
Carcinoembryonic Antigen (CEA) - Drugs in Development, 2021
US$ 3,000.00
Carcinoembryonic Antigen (CEA) - Drugs in Development, 2021 SUMMARY Carcinoembryonic Antigen (CEA) - Drugs in Development, 2021 provides in depth analysis on Carcinoembryonic Antigen (CEA) targeted pi...
April 2021
30 pages
Carcinoid Tumor (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Carcinoid Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Carcinoid Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Carcinoid Tumor pipeline landscape. The report provi...
April 2021
30 pages
Carcinomas (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Carcinomas (Oncology) - Drugs in Development, 2021 SUMMARY Carcinomas (Oncology) - Drugs in Development, 2021 provides an overview of the Carcinomas pipeline landscape. The report provides comprehensi...
April 2021
45 pages
Caspase (CASP or EC 3.4.22.) - Drugs in Development, 2021
US$ 3,000.00
Caspase (CASP or EC 3.4.22.) - Drugs in Development, 2021 SUMMARY Caspase (CASP or EC 3.4.22.) - Drugs in Development, 2021 provides in depth analysis on Caspase (CASP or EC 3.4.22.) targeted pipeline...
April 2021
30 pages
